Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

Trump gave the companies 60 days to voluntarily comply, threatening to "deploy every tool in our arsenal to protect American ...

Major pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.

The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

On July 9, 2025, the U.S. Food and Drug Administration (FDA) issued a letter from Commissioner for Human Foods Martin Makary and Deputy ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

Congratulations to Bristol Myers Squibb on winning the 2025 Gold Alexander Hamilton Award in Working Capital Management!

As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...